))
The Big Story is back with a second season! The news culture of our times is noisy, crowded, and honestly so confusing. This is why we are coming every fortnight on your podcast platforms to help you make sense of the new and now. With two new hosts, Anjali and Prateek, the second season of The Big Story will feature longer and well-rounded discussions with experts across science, culture, technology, politics, and more. Tune in on your preferred podcast platform!
Genentech’s Rapid Innovation Strategy to Deliver Exceptional Clinical Trial Experiences
Manage episode 317411771 series 2408553
By Greg Kefer, CMO, Lifelink Systems and Lifelink Systems. Discovered by Player FM and our community — copyright is owned by the publisher, not Player FM, and audio is streamed directly from their servers. Hit the Subscribe button to track updates in Player FM, or paste the feed URL into other podcast apps.
Genentech US Medical Affairs is involved in hundreds of concurrent clinical trials that involve a spectrum of participants and investigators. The world of clinical trials and therapy development has been evolving and now COVID-19 is forcing the industry to innovate in different ways as it deals with labor shortages, supply chain disruptions, and a new virtual-first patient engagement environment.
Nik Kolatkar, Vice President, Scientific Operations, US Medical Affairs at Genentech sat down with Greg Kefer to discuss his vision for reimagining the way trials are executed. In order to meet modern consumer expectations, Genentech is leveraging advanced conversational AI to engage trial participants, to diversify, to democratize, and to create a constant feedback mechanism — all made possible through simple, smart, interactive messaging on smartphones.
Nik also describes the Genentech Innovation Hub strategy and how that team takes a startup mindset predicated on looking horizontally across the organization to achieve small, quick wins and then scaling the technology that works across the entire project portfolio.
67 episodes
